TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
PharmaLex Sweden AB
Closing information (x1000 SEK)
Closing information | 2023/09 | 2022/12 | 2021/12 |
Turnover |
27,726
|
26,777
|
17,353 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
410
|
2,706
|
1,195 |
EBITDA |
416
|
2,723
|
1,212 |
Total assets |
9,935
|
9,293
|
7,101 |
Current assets |
9,894
|
9,241
|
7,033 |
Current liabilities |
7,306
|
5,466
|
5,415 |
Equity capital |
2,629
|
3,827
|
1,686 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
12
|
11
|
9 |
Financial ratios
Fiscal year | 2023/09 | 2022/12 | 2021/12 |
Solvency |
26.5%
|
41.2%
|
23.7% |
Turnover per employee |
2,310
|
2,434
|
1,928 |
Profit as a percentage of turnover |
1.5%
|
10.1%
|
6.9% |
Return on assets (ROA) |
4.1%
|
29.1%
|
16.8% |
Current ratio |
135.4%
|
169.1%
|
129.9% |
Return on equity (ROE) |
15.6%
|
70.7%
|
70.9% |
Change turnover |
949
|
9,424
|
3,437 |
Change turnover % |
4%
|
54%
|
25% |
Chg. No. of employees |
1
|
2
|
1 |
Chg. No. of employees % |
9%
|
22%
|
13% |
Total value of public sale
Fiscal year | 2023/09 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.